XML 32 R18.htm IDEA: XBRL DOCUMENT
v3.22.4

Income Taxes | 12 Months Ended
--- | ---
Dec. 31, 2022
Income Taxes |
Income Taxes | 10. Income Taxes The components of the income tax benefit (expense) provision are as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2022 |  | 2021 |  | 2020
Current: |  | ​ |  |  | ​ |  |  | ​ |
Federal | ​ | $ | (483) | ​ | $ | 1,065 | ​ | $ | —
State | ​ |  | (644) | ​ |  | (205) | ​ |  | (71)
Total current | ​ |  | (1,127) | ​ |  | 860 | ​ |  | (71)
Deferred | ​ |  |  | ​ |  |  | ​ |  |
Federal | ​ |  | 285 | ​ |  | 8,561 | ​ |  | 1,433
State | ​ |  | — | ​ |  | 852 | ​ |  | 327
Total deferred | ​ |  | 285 | ​ |  | 9,413 | ​ |  | 1,760
Income tax (expense) benefit | ​ | $ | (842) | ​ | $ | 10,273 | ​ | $ | 1,689
​ The tax effects of cumulative temporary differences that give rise to significant deferred tax assets and deferred tax liabilities are presented below. The valuation allowance relates to deferred tax assets for which it is more likely than not that the tax benefit will not be realized. ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, |  | December 31,
​ | ​ | 2022 | ​ | 2021
Deferred tax assets |  | ​ |  |  | ​ |
Accrued expenses and other | ​ | $ | 1,230 | ​ | $ | 1,080
Unrealized gain/loss on investments | ​ | ​ | 1,296 | ​ | ​ | —
Stock-based compensation | ​ | ​ | 1,626 | ​ | ​ | 1,753
Deferred revenue | ​ |  | 49,053 | ​ |  | 37,108
Goodwill | ​ |  | 6,378 | ​ |  | 357
Operating lease liabilities | ​ | ​ | 1,071 | ​ | ​ | 1,126
Loss and loss adjustment reserves | ​ | ​ | 16,392 | ​ | ​ | 11,971
Net operating losses | ​ |  | 100,920 | ​ |  | 87,802
Disallowed interest | ​ |  | 5,676 | ​ |  | 5,098
Research and development capitalized costs | ​ | ​ | 521 | ​ | ​ | —
Valuation allowance | ​ |  | (117,568) | ​ |  | (88,613)
Total deferred tax assets | ​ |  | 66,595 | ​ |  | 57,682
Deferred tax liabilities | ​ |  |  | ​ |  |
Property and equipment | ​ | ​ | (87) | ​ | ​ | (50)
Intangibles | ​ | ​ | (3,614) | ​ | ​ | (10,660)
Operating lease right-of-use assets | ​ | ​ | (1,026) | ​ | ​ | (1,091)
Deferred policy acquisition costs | ​ | ​ | (1,907) | ​ | ​ | (857)
Reinsurance balance due | ​ | ​ | (59,794) | ​ | ​ | (44,197)
Internally developed software | ​ |  | (590) | ​ |  | (1,180)
Total deferred tax liabilities | ​ |  | (67,018) | ​ |  | (58,035)
Net deferred tax liabilities | ​ | $ | (423) | ​ | $ | (353)
​ Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial accounting purposes and the amounts used for income tax purposes and the tax effect of the tax loss carryforwards. The Company has recorded a valuation allowance due to the uncertainty surrounding the ultimate realizability or recoverability of such assets. Management evaluates, on an annual basis, both the positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable and the amount of the valuation allowance. In its evaluation, the Company considered its cumulative losses as significant negative evidence. Based upon a review of the four sources of income identified within ASC 740, Accounting for Income Taxes, the Company determined that the negative evidence outweighed the positive evidence. At such time as it is determined that it is more likely than not the deferred tax assets are realizable, the valuation allowance will be reduced. The valuation allowance increased by $29.0 million for the year ended December 31, 2022 from $88.6 million at December 31, 2021, to $117.6 million at December 31, 2022. As of December 31, 2022, the Company had net operating loss carryforwards for federal tax purposes of approximately $410.9 million and $250.1 million for state income tax purposes, respectively, which may be used to offset future taxable income. The net operating loss carryforwards for federal tax purposes generated prior to January 1, 2018, will begin to expire in 2031, and the net operating loss carryforwards for state tax purposes began to expire in 2023. The net operating loss with an unlimited carryforward period is $313.2 million for federal tax purposes and $60.1 million for state tax purposes. Utilization of net operating loss and tax credit carryforwards are subject to certain limitations under Sections 382–384 of the Internal Revenue Code of 1986, as amended, in the event of a change in the Company’s ownership, as defined in current income tax regulations. The Company has determined that it has experienced a limited number of ownership changes in its history but does not expect the resulting limitations to impose any significant constraints on the benefit of its tax attributes. Additional ownership changes may occur in the future. A reconciliation of the income tax benefit (expense) provision to the amounts computed by applying the statutory federal income tax rate to earnings before income taxes is shown as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2022 | ​ | 2021 | ​ | 2020
Tax computed at federal statutory rate | ​ | $ | 32,701 | ​ | $ | 24,492 | ​ | $ | 11,702
State tax, net of federal tax benefit | ​ |  | 4,879 | ​ |  | 5,531 | ​ |  | 2,097
Loss on impairment | ​ |  | (3,836) | ​ |  | — | ​ |  | —
Equity compensation | ​ |  | (3,939) | ​ |  | 12,821 | ​ |  | 1,148
Officer compensation | ​ | ​ | (860) | ​ | ​ | (5,306) | ​ | ​ | (176)
Debt transactions | ​ |  | 4,808 | ​ |  | (1,791) | ​ |  | 824
Enacted tax rate changes | ​ |  | 90 | ​ |  | 123 | ​ |  | 159
Return to provision | ​ |  | (6,533) | ​ |  | (648) | ​ |  | 502
Valuation allowance | ​ |  | (27,724) | ​ |  | (25,296) | ​ |  | (13,764)
Other | ​ |  | (428) | ​ |  | 347 | ​ |  | (803)
Income tax benefit (expense) | ​ | $ | (842) | ​ | $ | 10,273 | ​ | $ | 1,689
​ The U.S. federal statutory tax rate is 21%, while the Company’s effective tax rate for 2022, 2021 and 2020 was (0.5)%, 8.8%, and 3.0%, respectively. The difference for all years is due primarily to the tax benefit of pre-tax book losses being offset by the valuation allowance. The Company also recorded deferred tax benefits in 2021 and 2020, resulting from the release of a portion of the Company’s valuation allowance due to new deferred tax liabilities arising from certain stock acquisitions. The Company files federal and state income tax returns. The Company is not currently under examination but is open to audit by the I.R.S. and state tax authorities for tax years beginning in 2012. The resolutions of any examinations are not expected to be material to these financial statements. As of December 31, 2022, there are no penalties or accrued interest recorded in the financial statements. The Company had no uncertain tax position reserves as of December 31, 2022 and 2021. ​ On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022. Based upon our analysis of the Inflation Reduction Act of 2022 and subsequently released guidance, we do not believe that its provisions will have a material impact on our financial statements. ​ For tax years beginning on or after January 1, 2022, the Tax Cuts and Jobs Act of 2017 (“TCJA”) eliminates the option to currently deduct research and development expenses and requires taxpayers to capitalize and amortize them over five years for research activities performed in the United States and 15 years for research activities performed outside the United States pursuant to IRC Section 174. Although Congress is considering legislation that would repeal or defer this capitalization and amortization requirement, it is not certain that this provision will be repealed or otherwise modified.

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 21 -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 17 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.5.Q1) -URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 14 -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 270 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -URI https://asc.fasb.org/topic&trid=2144680 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration